ArticleNaunyn-Schmiedeberg's archives of pharmacology2021

Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways.

Jaroon Wandee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.